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ABSTRACT: Multicomponent self-assembly of peptides is a powerful
strategy to fabricate novel functional materials with synergetic properties
that can be used for several nanobiotechnological applications. In the present
study, we used a coassembly strategy to generate an injectable ultrashort
bioactive peptide hydrogel formed by mixing a dipeptide hydrogelator with a
macrophage attracting short chemotactic peptide ligand. Coassembly does
not impede hydrogelation as shown by cryo-transmission electron
microscopy (cryo-TEM), scanning electron microscopy, and rheology.
Biocompatibility was shown by cytotoxicity assays and confocal microscopy.
The hydrogels release the entrapped skin antibiotic ciprofloxacin, among
others, in a slow and continuous manner. Such bioinspired advanced
functional materials can find applications as wound dressing materials to treat chronic wound conditions like diabetic foot ulcer.
■ INTRODUCTION
Molecular self-assembly plays a pivotal role in bottom-up
approaches to fabricating nanoscale materials with biotechno-
logical applications.1 In particular, biocompatible peptide
based architectures like vesicles, nanosheets, nanospheres,
nanotubes, and nanofibers generated by this means can serve
as tools for nanomedicine.2−8 For example, self-assembly in
peptides can lead to the formation of self-supporting three-
dimensional hydrogels that are composed of nanofiber
networks with high water content and high mechanical
strength and that are biodegradable and biocompatible with
organisms.1,4,7−10 Thus, they can act as reservoirs for the slow
and continuous release of entrapped bioactive molecules and
can also mimic the extracellular matrix, which enables their use
as drug delivery agents and as scaffolds for tissue engineering.
In addition to all these above features, peptide-based gels are
relatively easy and inexpensive to synthesize, characterize, and
decorate, which makes them more advantageous compared to
several other natural and synthetic hydrogels.10
Numerous hydrogelators based on fluorenylmethoxycarbon-
yl (Fmoc)-modified oligopeptides, canonical and noncanonical
single aromatic amino acids, DOPA, fluorinated Fmoc-
derivatives, and naphthyl-modified alanine have been re-
ported.11−15 In these cases, stacking interactions between
Fmoc groups typically drive self-assembly. An alternative to the
Fmoc group is the nonproteinogenic amino acid α,β-
dehydrophenylalanine (ΔPhe), which is known to trigger the
formation of hydrogels in the context of the ultrashort
sequence LΔF (Figure 1A).9 Such hydrogels can be
conjugated with different bioactive ligands that induce growth
and differentiation of various cell types. Functionalization can
be achieved by either pre- or post-self-assembly covalent
conjugation strategies.16−19 The main disadvantage of the
former is that the hydrogelating property of the short sequence
can be compromised by even small covalent modifications; the
main disadvantage of the latter is that subsequent to
hydrogelation the groups to be modified may be inaccessible,
resulting in low modification efficiency and batch-to-batch
variation. For these reasons, supramolecular peptide coassem-
bly has emerged as a promising approach.20−23 This non-
covalent approach is presently being used to generate different
novel structures with applications as light harvesting soft
materials, in catalysis, in enhancing the mechanical strength of
materials, and in tissue engineering.22
In the present study, we report a coassembly strategy for
generating an injectable ultra-short bioactive peptide hydrogel
that could be developed as a wound dressing material. The
components are the dipeptide hydrogelator LΔF and fMLF
(Figure 1A), the shortest known chemotactic factor that
attracts macrophages.24−26 Macrophage recruitment plays a
key role in wound healing, wherein the M2 phenotype secretes
a wide variety of growth factors (GFs) that in turn trigger a
cascade of events that attract several other cells, like fibroblasts,
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that aid in wound closure.27−29 A strategy such as this, which
ensures that endogenous GFs are spontaneously and
continuously supplied to the wound site, circumvents the
need to exogenously provide these in the form of recombinant
proteins that suffer from limitations due to their high cost of
production, low efficacy and safety, and rapid degradation in
vivo.30−32
■ RESULTS AND DISCUSSION
Coassembly and Hydrogel Characterization. LΔF was
prepared according to a previously reported solution phase
Figure 1. (A) Line structures of LΔF, fMLF isoniazid, ciprofloxacin, and amphotericin B. (B) Inversion test showing self-supporting hydrogels of
LΔF alone (upper) and LΔF + fMLF (1:1) (lower) and cartoons of hydrogels and the nanofibers comprising them in each case. (C) Cryo-
transmission electron microscopy (cryo-TEM) analysis of LΔF (upper) and LΔF + fMLF (1:1) (lower) hydrogels. (D) Time-dependent step-
strain rheological tests of LΔF and LΔF + fMLF (1:0.5) showing injectability and self-healing properties. Confocal microscopy images showing
viability of (E) U937 macrophages and (F) fibroblasts in 1% w/v LΔF + fMLF (1:0.5). (G) Monocyte/macrophage migration assay with untreated
cells, LΔF alone, and 1% w/v LΔF + fMLF (1:0.25). (H) Release profiles for isoniazid, ciprofloxacin, and amphotericin B from 1% w/v LΔF +
fMLF (1:0.25) hydrogel over a period of 5 days. (I) Release profile for ciprofloxacin from 0.5, 1, or 2% w/v LΔF + fMLF (1:0.25) hydrogel over a
period of 5 days.
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synthetic route (Supporting Information).9 fMLF was
synthesized on a solid support according to the Fmoc strategy
(Supporting Information). LΔF was coassembled with
increasing amounts of fMLF peptide ligand in the LΔF/
fMLF ratios 1:0.25, 1:0.5, and 1:1 (Supporting Information),
and the hydrogel properties of the mixtures were analyzed at
1% w/v in 0.8 M sodium acetate buffer, unless otherwise
indicated. A standard tube inversion test was carried out to
determine the formation of self-supporting hydrogels (Figure
1B), a property that fMLF alone does not have (data not
shown). All samples assembled to form self-supporting
hydrogels, indicating that fMLF does not perturb hydro-
gelation of LΔF.
To determine the elemental composition of the coassembled
nanofibers, energy-dispersive X-ray spectroscopy (EDX)
analysis of the hydrogels was carried out. Figure S3 shows
the EDX spectra of the nanofibers, in which the signals for
carbon (C), nitrogen (N), oxygen (O), sodium (Na), and
sulfur (S) are labeled accordingly. As expected, the spectrum of
LΔF displays no signal for sulfur, whereas the coassembled
nanofibers show sulfur contents that increase with LΔF/fMLF
ratio: 0.99% (1:0.25), 2.46% (1:0.5), and 3.08% (1:1). This
provides evidence that the nanofibers resulting from the
peptide mixtures are composed of both LΔF and fMLF
peptides.
Cryo-TEM analysis was performed to quantify the effect of
coassembly on the dimensions of the nanofibers that comprise
the hydrogel. Figure 1B shows cryo-TEM images of the
extreme cases LΔF and LΔF/fMLF (1:1), for which
nanofibers of diameter of 13 ± 2 and 16 ± 2 nm, respectively,
are observed (Figure S4). This suggests that the thickness of
the nanofibers that comprise the LΔF hydrogel increases in the
presence of fMLF, a trend that is also observed in the
intermediate samples 1:0.25 (14 ± 1 nm) and 1:0.5 (16 ± 2
nm) (Figures S4 and S5). The ultrastructure of the hydrogels
was determined by scanning electron microscopy (SEM).
Figure S6 shows dense networks of nanofiber bundles in all
cases. From a qualitative perspective, the thickness of the
bundles appears to increase with the concentration of the
fMLF peptide. The apparent increase in nanofiber diameter
could be attributed to intermolecular interactions, most likely
π−π stacking interactions between the phenyl (fMLF) and
dehydrophenyl groups (LΔF) of the two components.
To understand the effect of coassembly on peptide
secondary structure, circular dichroism (CD) studies were
performed and the values were normalized based on extinction
coefficient, path length, peptide concentration, and the number
of residues (Figure S7). LΔF was reported to form β-like as
well as extended structures and shows a characteristic strong
minimum at 275 nm.9 This is attributed to an excitation split
in the electronic transition state of the ΔPhe chromophore that
originates with a rigid mutual disposition of two or more ΔPhe
residues. CD studies indicated a slight decrease in intensity of
the minima at 275 nm with the increase in the fMLF content
in the mixtures; however, there is no indication of any
significant secondary structural change.
Taken together, the EDX, cryo-TEM, SEM, and CD data
indicate that LΔF and fMLF indeed coassemble within
hydrogel structures. The properties of these hydrogels were
further characterized in the context of a potential wound
dressing material.
Mechanical Strength/Injectability. Injectability of
wound dressing materials can provide defect margin adaptation
at the wound site.33−35 The rheology-based shear-thin recovery
of peptide hydrogels and the underlying mechanism was first
reported by Schneider and co-workers.36,37 In order to
determine the thixotropic behavior of the coassembled gels
reported here, the samples were subjected to time-dependent
step-strain rheological tests (Figure 1D). Storage modulus (G′)
values were measured for samples at 1% w/v. The G′ value of
LΔF alone is 132 kPa and that of LΔF/fMLF (1:1) is 189 kPa.
These values indicate that these coassembled hydrogels belong
to the class of soft hydrogels, materials which have been
shown, when multivalently displaying bioactive ligands, to have
potential applications in targeted drug delivery, tissue
engineering, and wound healing.20,27,38−41 The frequency
sweep rheology experiments (1−100 rad/s) carried out
indicate high stabilities for both samples, as the G′ and G″
(loss modulus) values were found to be independent of
frequency.
In these rheology tests, first a low strain (0.1%) was used,
followed by the application of a high strain (50%) and then a
reversion of strain back to 0.1%. The high strain of 50% here
represents the kind of force typically experienced by the
hydrogels during uptake into a syringe. Both LΔF and LΔF/
fMLF (1:1) possess a solid gel-like structure (G′ > G″) with
stable and higher G′ and G″ values during the initial 0.1% low
strain. With the application of a high strain of 50%, a transition
from solid gel into liquid-like material is indicated by the rapid
decline in G′ and G″ values, with G′ < G″. Upon reverting to
0.1% low strain, the gels appear to regain their original
strength, with G′ > G″. These data indicate that coassembly
does not alter the injectability of LΔF and that the ligand
mixed hydrogels also have the ability to withstand stress and to
self-heal.
Biocompatibility. Biocompatibility is essential for the
successful application of wound dressing materials. Thus, the
viabilities of HEK293T, macrophages, and fibroblasts upon
exposure to LΔF and the coassemblies at 0.5, 1.0, and 1.5% w/
v were determined. Figure S8 shows the CCK8-based cell
viability assay conducted on the hydrogels seeded with cells
after 48 h of plating. None of the hydrogel formulations shows
any toxicity to the tested cell lines. This would indicate the
potential of these ligand coassembled hydrogels for use as
scaffolds for wound therapy. Furthermore, the hydrogels were
tested for their ability to act as three-dimensional scaffolds for
the growth of macrophages and fibroblasts. Figures 1E,F show
images obtained by confocal microscopy studies indicating
viability of both cell lines in LΔF/fMLF gels. The cell culture
was continuously supplemented with IL4 to maintain macro-
phages in the M2 phenotype. The proliferation of fibroblasts in
1% w/v LΔF + fMLF (1:0.25) was analyzed indirectly by
PrestoBlue assay, which indicated a progressive increase in
cellular metabolism of these cultures from day 0 to day 14
(Figure S9).
Macrophage Recruitment. Wound dressing materials
that recruit macrophages to the wound site are beneficial as
they can enable a continuous supply of endogenous GFs. To
find the ability of the LΔF/fMLF hydrogel to attract U937
monocyte/macrophage, a chemotactic migration assay was
performed, which shows that coassembly does not affect the
chemoattractant property of fMLF (Figure 1G).
Drug Entrapment and Release. Infections at the wound
site can hamper the healing process in normal wounds, and, in
the case of chronic wound conditions like diabetic foot ulcer
(DFU), it usually leads to amputation. Such complications
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currently necessitate the need for the coadministration of
antibiotics at the wound site to prevent infection. The
drawbacks to conventional drug delivery methods are that
repeated administration of the drug is required and that this is
characterized by burst release. Such burst release profiles are
undesirable because they can be pharmacologically dangerous,
causing unnecessary nonspecific cytotoxicity, not to mention
that this type of administration route is economically
inefficient due to the need for a large excess of the drug.
As an alternative, hydrogel matrices composed of a network
of nanofibers can be used as a reservoir to entrap and release
small-molecule drugs, macromolecular drugs, and even
engineered cells in a slow and continuous manner controlled
by diffusion. Furthermore, the hydrogel matrix can reduce
degradation of the entrapped drug. The applicability of peptide
gels for slow and continues release of entrapped drugs and GFs
is widely reported.42−46 In order to determine the drug release
profiles of LΔF and coassembled 1% w/v LΔF/fMLF
(1:0.25), different drugs at a concentration of 4 mM were
individually entrapped. The drugs isoniazid, amphotericin B,
and ciprofloxacin were chosen for the following reasons.
Isoniazid and amphotericin B are standard drugs used for
killing the macrophage intracellular pathogen Mycobacterium
tuberculosis, a causative agent of tuberculosis, and Leishmania
donovani, a causative agent of leishmaniasis. Ciprofloxacin is a
standard antibiotic used to treat wound infections, and it is
effective against numerous devastating bacterial species
including Klebsiella pneumoniae, methicillin-susceptible Staph-
ylococcus aureus, and Streptococcus pyogenes.
The percentage of drug release from the nanofiber gel matrix
into the overlaying phosphate-buffered saline at pH 7.4 was
quantified by means of UV/Vis spectroscopy. Figure 1H shows
the release profiles of these three drugs from the hydrogel over
a span of 5 days. As seen from the drug release profiles, the
coassembled hydrogels exhibit a slow and continuous release of
the entrapped drugs as opposed to a burst release. The
dissimilarity of the release profiles can be attributed to the
different net charge, molecular weight, and hydrophobicity of
the molecules (Figure S10). All three have no net charge at
neutral pH and so their charge-based interactions with the
hydrogel network can be ruled out. Release is slowed as
molecular weight and hydrophobicity increase.
To achieve controlled and effective drug delivery, fine-tuning
the factors that can increase or decrease the amount of drug
released from the hydrogel matrix over time is essential. One
such regulatory factor is the mesh size of the hydrogel, which is
a concentration-dependent property. LΔF has been reported
to show self-assembly into nanogels or hydrogels in a
concentration-dependent manner.9 Nanogels are a nano-
particulate form of hydrogels. At 0.3−0.4% w/v it exists as a
nanogel, while at concentrations higher than 0.5% w/v it forms
self-supporting hydrogels. At 0.3% w/v, it exhibits a network of
small fibers of length 100 nm with higher mesh size, while at
0.4% w/v it shows relatively longer fibers with a decreased
mesh size. Within the hydrogel regime, the mesh size decreases
further with an increase in peptide concentration. For this
reason, we investigated the influence of LΔF/fMLF (1:0.25)
coassembly concentration on ciprofloxacin release. To this end
4 mM ciprofloxacin was entrapped in 0.5, 1, or 2% w/v
hydrogels, and its release profile determined as above. Figure
1I shows that the hydrogelator concentration does affect the
drug release, as the percentage drug released from the 2% w/v
hydrogel is about 50% lower than in the case of 0.5% w/v after
120 h. The coassembled gels 1% w/v LΔF + fMLF (1:0.25)
also showed ability to entrap and release interleukin-4 in a slow
and continuous manner for a duration of about 6 days (Figure
S11).
■ CONCLUSIONS
In summary, a coassembly strategy to generate multivalent
supramolecular peptide hydrogel scaffolds that can act as
wound dressing materials was investigated. The dipeptide
hydrogelator LΔF and the macrophage chemotactic peptide
ligand fMLF were coassembled and the properties of the
resulting hydrogels were determined by a variety of means. CD
spectroscopy demonstrated that coassembly did not change
the secondary structural features of LΔF, whereas rheology
indicated that the mechanical strength and injectability of the
gels remains unaltered. Electron micrographs suggest an
increase in nanofiber thickness with increasing ligand density,
whereas EDX analysis shows that the coassembled nanofibers
are composed of both peptides based on the presence of a
sulfur signal. The fMLF ligand in the coassembled gel was
found to attract macrophage. As macrophage recruitment is
important in wound healing, wherein it activates several other
cascades of events by producing GFs; this property is highly
advantageous. The hydrogel matrix has the ability to entrap
and release different types of drugs in a slow and continuous
manner. One of the drugs investigated here is ciprofloxacin, an
antibiotic that can prevent wound site infections. The impact
of mesh size on drug release was also investigated. The ability
of these coassembled hydrogels to support three-dimensional
growth of macrophages and fibroblasts was demonstrated by
means of confocal microscopy. All these features indicate the
potential of this coassembled hydrogel to be developed as a
wound-dressing material in treating chronic conditions like
DFU. The kind of simple molecular coassembly approach to
identifying bioactive ultrashort peptide hydrogelators shown
here can be used for a significant expansion of the repertoire of
such functional biomaterials for nanomedicine-based applica-
tions.
■ EXPERIMENTAL SECTION
Cryo-TEM Sample Preparation and Analysis. Droplets
(5 μL) of aqueous samples of LΔF and LΔF/fMLF at molar
ratios of 1:0.25, 1:0.5, and 1:1 in 0.8 M sodium acetate buffer
at pH 7.4 were placed on hydrophilized [plasma treatment
using a BALTEC MED 020 device (Leica Microsystems,
Wetzlar, Germany)], perforated carbon filmed grids (Quanti-
foil Micro Tools GmbH, Jena, Germany). Excess fluid was
blotted off to create an ultrathin layer (typical thickness 200−
300 nm) of the solution, which spanned the holes of the
support film. The prepared samples were immediately vitrified
by propelling the grids into liquid ethane at its freezing point
(−184 °C). The vitrified sample grids were transferred under
liquid nitrogen by the use of a Gatan (Pleasanton, CA, USA)
cryo-holder (model 626) into a Tecnai F20 TEM (FEI
company, Oregon, USA) equipped with FEG and operated at
160 kV acceleration voltage. Microscopy was carried out at
−175 °C sample temperature using the microscope’s low dose
protocol at calibrated primary magnifications of 50k or 29k.
The defocus was set to be 3.98 or 9.81 μm, respectively.
Images were recorded by the use of a 4k-Eagle CCD camera
(FEI Company, Oregon, USA) at 2k resolution (binning 2).
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3D Cell Viability and Growth. 1% w/v LΔF/fMLF
(1:0.25) hydrogels were prepared in 8-well plates and
incubated in a cell culture hood overnight to allow methanol
evaporation. Subsequently, 200 μL of Dulbecco’s modified
Eagle’s medium (DMEM) with a density of 1 × 104 fibroblast
cells per well were transferred onto the gel surface and
incubated with 5% CO2 at 37 °C overnight. Nonadherent cells
were aspirated, and the plates were maintained in the incubator
for 15 days with continuous exchange of spent media with
fresh DMEM. The cells that adhered and migrated into the
gels were stained with Calcein-AM and observed under
confocal microscopy. Untreated cells served as the control.
For the 3D growth of U937 cells 1% w/v LΔF/fMLF (1:0.25),
hydrogels were prepared in 8-well plates and left in a cell
culture hood overnight to allow methanol evaporation.
Subsequently, 200 μL RPMI with a density of 1.5 × 106
U937 cells per mL were transferred onto the gel surface and
incubated with 5% CO2 at 37 °C for 24 h. Nonadherent cells
were aspirated, and adherent cells differentiated into macro-
phages by treating the gels with RPMI containing 100 nM
phorbol 12-myristate 13-acetate (Sigma Aldrich) for a duration
of 24 h, followed by incubation in RPMI media for another 24
h. The cells were further differentiated to M2 polarization by
treating the gels with IL-4 (20 ng per mL) for the next 72 h.
Subsequent cultivation was done in RPMI media for the next 9
days with continuous exchange of spent media with fresh
media. The cells that adhered and migrated into the gels were
stained with LIVE/DEAD Viability/Cytotoxicity Kit (Invi-
trogen) and observed under confocal microscopy. Untreated
cells served as the control. To quantify growth, fibroblasts were
cultured in 1% w/v LΔF/fMLF (1:0.25) hydrogels under
conditions described above. At predetermined time intervals
from day 0 to day 14, the cell culture media in the plates was
replaced with 10% (v/v) PrestoBlue-fresh medium mixture for
3 h. After incubation, 100 μL of this media is removed and its
fluorescence intensity is monitored at excitation 550 nm and
emission 590 nm. Analysis was done in triplicate (Figure S9).
Chemotactic Assay. A chemotactic assay was conducted
for 1% w/v LΔF/fMLF (1: 0.25) hydrogels by means of
CytoSelectTM 24-well cell migration assay kit (Cell biolabs,
INC) containing 5 μm pore size PET membrane inserts in a
24-well plate. The migratory cells were quantified by CyQuant
GR Dye (Invitrogen). A well containing only LΔF gel and
another containing only cell culture media (without any gel)
served as negative controls, while soluble fMLF peptide at an
equimolar concentration served as a positive control. The test
samples were normalized to the fluorescence of fMLF exposed
samples and were multiplied by 100%.
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